Italia markets open in 2 hours 45 minutes

Onxeo SA (0NWK.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
0,3720+0,3720 (+75,09%)
Alla chiusura: 06:23PM BST
Schermo intero
Chiusura precedente0,7305
Aperto0,3720
Denaro0,0000 x 0
Lettera0,0000 x 0
Min-Max giorno0,3720 - 0,3720
Intervallo di 52 settimane0,3720 - 0,3720
Volume1.500
Media VolumeN/D
Capitalizzazione21,02M
Beta (5 anni mensile)1,22
Rapporto PE (ttm)N/D
EPS (ttm)-0,0700
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Onxeo Continues to Strengthen its Board of Directors

    Bryan Giraudo, COO & CFO of U.S. biopharmaceutical company Gossamer Bio, joins the Company’s Board as independent member Paris (France), Nov. 23, 2021 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxeo », a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, today announced the appointment of Bryan Giraudo as independent member of the Board of Directors, repl

  • GlobeNewswire

    Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector

    Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company’s Board as independent members Paris (France), Oct. 14, 2021 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxeo », a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, today announced the a